Le Lézard
Classified in: Health, Science and technology
Subject: Stock Sale/Buyback

HEALIOS K.K. Increases Investment in Athersys by Fully Exercising Warrant to Acquire Additional Shares


Athersys, Inc. ("Athersys") (NASDAQ: ATHX) announced today that its partner in Japan, HEALIOS K.K. ("Healios"), exercised in full its warrant to purchase shares of Athersys common stock. Healios purchased 4,000,000 shares at a price of $1.76 per share in accordance with the terms of the warrant, representing an additional investment of $7,040,000 in Athersys.

This warrant was issued to Healios in March 2018 as part of an expansion of the collaboration between the companies. This expansion agreement set the warrant exercise price at 110% of the average price per share over the ten days preceding exercise, or $1.76 per share so long as the reference price remained below this floor.

Healios previously purchased 12,000,000 shares of Athersys common stock and now owns approximately 9.4% of the current outstanding shares of Athersys. There are no other warrants outstanding.

About Athersys

Athersys is a biotechnology company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. The Company is developing its MultiStem® cell therapy product, a patented, adult-derived "off-the-shelf" stem cell product, initially for disease indications in the neurological, inflammatory and immune, cardiovascular and other critical care indications and has several ongoing clinical trials evaluating this potential regenerative medicine product. Athersys has forged strategic partnerships and a broad network of collaborations to further advance the MultiStem cell therapy toward commercialization. More information is available at www.athersys.com. Follow Athersys on Twitter at www.twitter.com/athersys.


These press releases may also interest you

at 23:40
Trip.com Group Limited ("Trip.com Group" or the "Company"), a leading provider of online travel and related services, including accommodation reservation, transportation ticketing, packaged-tour and in-destination services, corporate travel...

at 23:05
iProov today announces its partnership with Australian identity verification specialists IDV Pacific Pty Ltd. The announcement sees iProov expand its growing partner network and extend its services into Australia and New Zealand. IDV Pacific...

at 22:45
Relevium Technologies Inc. (the "Company" or "Relevium") is pleased to announce it has entered into a Letter of Intent ("LOI") with H-Source Holdings, a leading secure and trusted Personal Protective Equipment ("PPE") platform, to partner in the...

at 22:35
Rootstock Software ? a leading provider of cloud Enterprise Resource Planning (ERP) solutions built on the Salesforce Platform, designed for manufacturing, distribution and supply chain organizations, and available on the Salesforce AppExchange ?...

at 22:12
Applied Information Sciences (AIS) today announced it has been awarded the Business Applications ? Power Apps and Power Automate 2020 Microsoft Partner of the Year Award. The company was honored among a global field of top Microsoft partners for...

at 21:30
Arctic Vision, a clinical-stage biotechnology company incubated by Nan Fung Life Sciences and Pivotal BioVenture Partners China in 2019, today announced its $32mn Series A financing led by Morningside Ventures, together with its existing investors....



News published on 30 march 2020 at 06:05 and distributed by: